Its structural changes reduce the inhibitory effect on P-glycoprotein (P-gp), enhance its cell membrane penetration ability, and compromise efflux tendency, thereby improving its killing efficiency against tumor cells (Sun et al., 2023). The gene discussed is ABCB1; the disease is neoplasm.